Risk factors
Talphera (TLPH) risk factors
Item 1A of every Talphera, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors57 risks2 new6 dropped7 reworded
Alora stopped non-DoD sales of DSUVIA and requested NDA withdrawal, threatening destruction of remaining inventory without DoD orders. Nasdaq issued a minimum bid price deficiency notice on March 11, 2026, threatening delisting.
Filed Mar 23, 2026 - FY2024 10-K risk factors61 risks
Talpher operates as a clinical-stage biopharmaceutical and medical device company facing going-concern doubts.
Filed Mar 31, 2025